Virtual Reality for Urological Procedures

January 20, 2025 updated by: Renée El-Gabalawy, University of Manitoba

Feasibility of a Virtual Reality Intervention for Patients Undergoing Urological Procedures

It is standard practice for most cystoscopies and vasectomies in an office or outpatient setting to be performed under local anesthesia while the patient is awake and conscious. However, given the conscious nature of these procedures, patients may experience anxiety-inducing stressors that they otherwise would not under general anesthesia. Stressors such as hearing surgical terminology, technical discussion, and injection of local anesthetic have been previously documented as sources of perioperative anxiety and pain in awake surgeries.

The current study will examine the feasibility and pilot outcomes of Virtual Reality (VR) guided meditation therapy during cystoscopies and vasectomies. Feasibility will be examined through: (1) recruitment capability and resulting sample characteristics, (2) data collection procedures (including randomization) and outcome measures, and (3) participant acceptability and suitability of the VR intervention during the procedures. The investigators will also evaluate pilot outcomes of the VR intervention on pain, anxiety, and overall satisfaction with the procedure. Results of this study will inform the development of a large-scale randomized clinical trial (RCT) to evaluate the efficacy of this intervention.

Participants will be asked to complete questionnaires before and after their procedure and will be asked for a verbal measure of their pain and anxiety during the procedure.

Study Overview

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Manitoba
      • Winnipeg, Manitoba, Canada, R3P 2S8
        • Men's Health Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18 years of age or older
  • can speak and read English
  • have an indication for a cystoscopy or elected for a vasectomy
  • are scheduled to undergo their respective procedure under local anesthesia at the Men's Health Clinic between the dates of May-November 2024.

Exclusion Criteria:

  • those who are not competent to provide informed consent (e.g., due to cognitive impairment)
  • those who are unable to participate in a VR intervention (e.g., due to visual or auditory impairment)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cystoscopy VR intervention
Local anesthetic and VR intervention
Tripp application on Meta Quest 3 VR headset
Active Comparator: Cystoscopy treatment as usual
Local anesthetic only
No VR, local anesthetic only
Experimental: Vasectomy VR intervention
Local anesthetic and VR intervention
Tripp application on Meta Quest 3 VR headset
Active Comparator: Vasectomy treatment as usual
Local anesthetic only
No VR, local anesthetic only

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rate
Time Frame: through study completion, up to 1 year
Proportion of individuals who consent to participation and the number of recruited participants per week
through study completion, up to 1 year
Inclusion criteria and demographic and surgery-related differences
Time Frame: through study completion, up to 1 year
Proportion of individuals who meet inclusion criteria and any demographic and surgery-related differences in potentially eligible participants
through study completion, up to 1 year
Retention of participants in the study
Time Frame: Immediate post-operative
Proportion of individuals who tolerate the intervention and complete the study
Immediate post-operative
Acceptability through elevate scores on the Virtual Reality Impression Scale
Time Frame: Immediate post-operative
Acceptability of the VR program during urological procedures (0 thru 100, 100=positive impressions)
Immediate post-operative
Impressions of the VR based on open-ended responses on the Virtual Reality Impression Scale
Time Frame: Immediate post-operative
Negative and positive impressions of the VR intervention (open ended/qualitative)
Immediate post-operative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scores on the National Comprehensive Cancer Network (NCCN) Distress Thermometer (and adapted Anxiety Thermometer)
Time Frame: Pre-operative, acute post-operative (immediately following surgery)
Brief self-report visual analogue scales (VAS) for anxiety/distress (0 thru 10, 10=worse anxiety/distress)
Pre-operative, acute post-operative (immediately following surgery)
Visual Analogue Scale pain severity
Time Frame: Peri-operative (mid-way through procedure)
Brief self-report visual analogue scales (VAS) for acute pain (o thru 10, 10=more severe pain)
Peri-operative (mid-way through procedure)
Visual Analogue Scale anxiety severity
Time Frame: Peri-operative (mid-way through procedure)
Brief self-report visual analogue scales (VAS) for acute anxiety (0 thru 10, 10=more severe anxiety)
Peri-operative (mid-way through procedure)
State Trait Anxiety Inventory (STAI) elevated scores
Time Frame: Pre-operative, acute post-operative (immediately following surgery)
Brief self-report questionnaire with questions surrounding anxiety traits (0 thru 63, higher score=more severe anxiety)
Pre-operative, acute post-operative (immediately following surgery)
PROMIS Pain Intensity Scale total score
Time Frame: Acute post-operative (immediately following surgery)
Brief self-report questionnaire with questions surrounding experienced pain (3 thru 15, 15=greater pain severity)
Acute post-operative (immediately following surgery)
Satisfaction With Surgery score
Time Frame: Acute post-operative (immediately following surgery)
Item to assess overall satisfaction with surgery (0 thru 10, 10=greater satisfaction)
Acute post-operative (immediately following surgery)
Subjective assessment of time spent in VR vs. actual time in VR
Time Frame: Evaluated immediate post-operative
Perception of time during procedure compared to actual time among those in VR
Evaluated immediate post-operative
i-Group Presence Questionnaire (IPQ) score
Time Frame: Acute post-operative (immediately following surgery)
Brief self-report questionnaire with questions surrounding VR experience (spatial presence, involvement, experience realism), higher scores=greater presence
Acute post-operative (immediately following surgery)
Selection of VR experience
Time Frame: Pre-operative
What Tripp experience that participants select (out of 5 potential programs)
Pre-operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Renee El-Gabalawy, PhD, University of Manitoba
  • Principal Investigator: Premal Patel, MD, University of Manitoba
  • Principal Investigator: Simone Gentile, BSc, University of Manitoba

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2024

Primary Completion (Actual)

November 1, 2024

Study Completion (Actual)

November 1, 2024

Study Registration Dates

First Submitted

July 12, 2024

First Submitted That Met QC Criteria

July 31, 2024

First Posted (Actual)

August 2, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 20, 2025

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • HS26202

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Virtual reality (VR) guided meditation therapy

Subscribe